Results of Induction of Labor with Prostaglandins E1 and E2 (The RIPE Study): A Real-World Data Analysis of Obstetrical Effectiveness and Clinical Outcomes of Pharmacological Induction of Labor with Vaginal Inserts

• Published in: Pharmaceuticals (Basel, Switzerland) Vol. 16; no. 7; p. 982
• Main Authors: Socha, Maciej W, Flis, Wojciech, Pietrus, Miłosz, Wartęga, Mateusz
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.07.2023; MDPI
• Subjects: Cervix; Childbirth & labor; delivery; Dosage and administration; Gestational age; Hormones; Induced labor; induction of labor; labor; Labor, Induced (Obstetrics); Obstetrics; Patient outcomes; patients’ clinical outcomes; Pregnancy; Prostaglandins; real-world data; Testing; Vagina; Poland; delivery; induction of labor; Dinoprostone; pregnancy outcome; real-world data; obstetrics; Misoprostol; patients’ clinical outcomes; labor
• ISSN: 1424-8247; 1424-8247
• DOI: 10.3390/ph16070982

Despite extensive knowledge of the mechanisms responsible for childbirth, the course of labor induction is often unpredictable. Therefore, labor induction protocols using prostaglandin analogs have been developed and tested to assess their effectiveness in labor induction unequivocally. A total of 402 women were collected into two groups-receiving vaginal Misoprostol or vaginal Dinoprostone for induction of labor (IOL). Then, the patients were compared in groups depending on the agent they received and their gestational age. Most patients delivered within 48 h, and most of these patients had vaginal parturition. Patients who received the Dinoprostone vaginal insert required statistically significantly more oxytocin administration than patients who received the Misoprostol vaginal insert. Patients who received the Misoprostol vaginal insert used anesthesia during labor statistically more often. Patients who received Misoprostol vaginal inserts had a statistically significantly shorter time to delivery than those with Dinoprostone vaginal inserts. The prevalence of hyperstimulation was similar in all groups and remained low. Vaginal Misoprostol-based IOL is characterized by a shortened time to delivery irrespective of the parturition type, and a lower need for oxytocin augmentation, but also by an increased demand for intrapartum analgesia administration. A vaginal Dinoprostone-based IOL protocol might be considered a more harmonious and desirable option in modern perinatal care.